NephSAP: Active Issues
57
2.1MB
Most of the glomerular diseases patients I see come to my office for a second opinion, brandishing stacks of paper from their prior medical encounters.
→
Volume 18, Number 1, March 2019
Primary Glomerular Diseases
Richard J. Glassock, MD
AMA PRA Category 1 Credits™
Most of the glomerular diseases patients I see come to my office for a second opinion, brandishing stacks of paper from their prior medical encounters....
80
4.1MB
This issue of NephSAP on end-stage renal disease (ESRD) and dialysis discusses the most recent survival data and, importantly, examines other traditional and nontraditional clinical outcomes, including quality of life (QoL), cognition, cardiovascular dise
→
Volume 17, Number 5, November 2018
End-Stage Renal Disease and Dialysis
Ruediger W. Lehrich, MD and John P. Middleton, MD
AMA PRA Category 1 Credits™
This issue of NephSAP on end-stage renal disease (ESRD) and dialysis discusses the most recent survival data and, importantly, examines other traditional and nontraditional clinical outcomes, including quality of life (QoL), cognition, cardiovascular dise...
80
1.4MB
Focal segmental glomerulosclerosis (FSGS) and collapsing glomerulopathy (CG) are distinct clinical pathologic syndromes that are associated with podocyte injury and podocyte precursor dysfunction, respectively.
→
Volume 17, Number 4, September 2018
Secondary Glomerular Diseases
Brad H. Rovin, MD
AMA PRA Category 1 Credits™
Focal segmental glomerulosclerosis (FSGS) and collapsing glomerulopathy (CG) are distinct clinical pathologic syndromes that are associated with podocyte injury and podocyte precursor dysfunction, respectively....
70
3.8MB
Since the early 2000s, investigators have been studying the regulation and effects of elevated fibroblast growth factor 23 (FGF23) levels in the setting of CKD.
→
Volume 17, Number 3, August 2018
Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis
Stanley Goldfarb, MD and Kevin J. Martin, MBBCh
AMA PRA Category 1 Credits™
Since the early 2000s, investigators have been studying the regulation and effects of elevated fibroblast growth factor 23 (FGF23) levels in the setting of CKD....
101
3.3MB
This issue of NephSAP is dedicated to interventional nephrology. This discipline was a nascent field in 2003 when all 18 ESRD Networks and the Centers for Medicare and Medicaid Services (CMS), together with clinicians, dialysis providers, and patients, de
→
Volume 17, Number 2, June 2018
Interventional Nephrology and Dialysis Access
Anil K. Agarwal MD, Lalathaksha Murthy Kumbar MD and Vandana Dua Niyyar MD
AMA PRA Category 1 Credits™
This issue of NephSAP is dedicated to interventional nephrology. This discipline was a nascent field in 2003 when all 18 ESRD Networks and the Centers for Medicare and Medicaid Services (CMS), together with clinicians, dialysis providers, and patients, de...
130
6.1MB
The quest to define the lower limits and perfusion requirements of the human kidney has never been more challenging.
→
Volume 17, Number 1, March 2018
Hypertension
Debbie L. Cohen, MD, Karen A. Griffin, MD
AMA PRA Category 1 Credits™
The quest to define the lower limits and perfusion requirements of the human kidney has never been more challenging....
98
3.4MB
The hepatitis C virus (HCV) is a small, enveloped, single-stranded RNA virus from the family Flaviviridae. This virus is transmitted by contact with small amounts of blood and can also be transmitted sexually and from mother to baby; it is estimated that
→
Volume 16, Number 4, November 2017
Transplantation
John P. Vella, MD and Alexander C. Wiseman, MD
AMA PRA Category 1 Credits™
The hepatitis C virus (HCV) is a small, enveloped, single-stranded RNA virus from the family Flaviviridae. This virus is transmitted by contact with small amounts of blood and can also be transmitted sexually and from mother to baby; it is estimated that ...
104
7MB
CKD affects >26 million Americans and can lead to early cardiovascular disease and kidney failure (1,2). CKD has a variable course, and predicting its rate of progression can help identify high-risk individuals for personalized interventions (3).
→
Volume 16, Number 3, September 2017
Chronic Kidney Disease and Progression
Holly J. Kramer, MD and Sankar D. Navaneethan, MD
AMA PRA Category 1 Credits™
CKD affects >26 million Americans and can lead to early cardiovascular disease and kidney failure (1,2). CKD has a variable course, and predicting its rate of progression can help identify high-risk individuals for personalized interventions (3)....
88
2.2MB
AKI is a common and serious medical condition associated with significant increases in morbidity, mortality, and cost of care.
→
Volume 16, Number 2, May 2017
Acute Kidney Injury and Critical Care Nephrology
Jay L. Koyner, MD and Charuhas V. Thakar, MD
AMA PRA Category 1 Credits™
AKI is a common and serious medical condition associated with significant increases in morbidity, mortality, and cost of care....
All active issues are eligible for Continuing Medical Education (CME) credit. Please note: Beginning with the January 2007 issue, all NephSAP issues will be available online by the 15th of the month. You can get notified when new issues are posted by subscribing to the RSS feed.
NephSAP is included as part of the ASN Member Benefits package and is available online for all current ASN members. Non-members can purchase a one-year subscription to the online version that includes online-only access to the active issues, archives, podcast, and the ability to claim CME credit.